Psilocybin for Anxiety: Ontario Clinical Trial Launches

Psilocybin clinical trial anxiety Canada: Psilocybin for Anxiety: Ontario Clinical Trial Launches

Kingston Health Sciences Centre in Ontario has launched a regulated clinical trial examining whether psilocybin-assisted therapy can reduce anxiety. The trial is in an early enrollment phase, and no outcome data have been reported yet. No conclusions about effectiveness can be drawn at this stage. Key takeaways A Canadian institution is now running this work: […]

One Dose, Two Years: Psilocybin and Depression in Cancer Patients

Psilocybin for cancer depression: One Dose, Two Years: Psilocybin and Depression in Cancer Patients - The Church of Psychedelics

A single 25 mg dose of psilocybin, given alongside structured psychological support, produced measurable reductions in depression and anxiety that held for up to two years in a group of cancer patients. Those are the findings of a phase 2 trial now published in Cancer, the peer-reviewed journal of the American Cancer Society, and they […]